Method for genome sequencing using a sequence-based physical map
Abstract
The present invention relates to a high throughput method for the identification and detection of molecular markers wherein restriction fragments are generated and suitable adaptors comprising (sample-specific) identifiers are ligated. The adapter-ligated restriction fragments may be selectively amplified with adaptor compatible primers carrying selective nucleotides at their 3′ end. The amplified adapter-ligated restriction fragments are, at least partly, sequenced using high throughput sequencing methods and the sequence parts of the restriction fragments together with the sample-specific identifiers serve as molecular markers.
Claims
exact text as granted — not AI-modified1 . A method for the generation of a physical map of at least part of a genome comprising the steps of:
(a) generating an artificial chromosome clone bank wherein each artificial chromosome clone contains part of a sample DNA; (b) combining the artificial chromosome clones in one or more pools, wherein each clone is present in more than one pool, to create a library; (c) digesting the one or more pools with one or more restriction endonucleases to provide restriction fragments for each pool; (d) ligating adaptors to one or both sides of the restriction fragments, wherein at least one adaptor contains a pool-specific identifier or a degenerate identifier section to provide adaptor-ligated restriction fragments; (e) optionally, combining the adaptor-ligated restriction fragments; (f) amplifying the adaptor-ligated restriction fragments of step (d) with at least one primer, which primer contains a pool-specific section corresponding to the pool-specific identifier section in the adaptor or contains a pool-specific identifier at the position of the degenerate identifier section, respectively, to provide amplified adaptor-ligated restriction fragments (amplicons); (g) optionally, combining the amplicons in a set of combined amplicons; (h) determining the sequence of at least the pool-specific identifier and part of the restriction fragment of the amplicons or set of combined amplicons; (i) assigning the restriction fragment sequences determined in the amplicons of step (h) to the corresponding clones using the pool-specific identifiers; (j) ordering the restriction fragments derived from the same clone to build a contig; (k) ordering the contigs of the clones of step (j) to thereby build a clone-contig and generate a physical map.
2 . The method according to claim 1 , wherein the restriction fragments are assigned to the corresponding clone by clustering amplicons that contain identical sequences in the restriction fragments but carry different pool-specific identifiers.
3 . The method according to claim 1 , wherein the sequencing is carried out by means of high-throughput sequencing.
4 . The method according to claim 3 , wherein the high-throughput sequencing is performed on a solid support.
5 . The method according to claim 3 , wherein the high-throughput sequencing is based on Sequencing-by-Synthesis.
6 . The method according to claim 3 , wherein the high-throughput sequencing comprises the steps of:
annealing the amplicons or adapter-ligated restriction fragments to beads, each bead annealing with a single adapter-ligated restriction fragments or amplicon; emulsifying the beads in water-in-oil micro reactors, each water-in-oil micro reactor comprising a single bead; performing emulsion PCR to amplify adapter-ligated restriction fragments or amplicons on the surface of beads, optionally, selecting and enriching beads containing amplified amplicons; loading the beads in wells, each well comprising a single bead; and generating a pyrophosphate signal.
7 . The method according to claim 3 , wherein the high-throughput sequencing comprises the steps of:
annealing the adapter-ligated restriction fragments or amplicons to a surface containing first and second primers or first and second primer binding sequences respectively, performing bridge amplification to provide clusters of amplified adapter-ligated restriction fragments or amplified amplicons, determining the nucleotide sequence of the amplified adapter-ligated restriction fragments or amplified amplicons using labelled reversible terminator nucleotides.
8 . The method according to claim 1 , wherein the identifier is from 4-16 bp.
9 . The method according to claim 8 , wherein the identifier does not contain 2 or more identical consecutive bases.
10 . The method according to claim 8 , wherein for two or more clones, the corresponding identifiers contain at least two different nucleotides.
11 . The method according to claim 1 , wherein the at least one primer carries 1-10 selective nucleotides at it 3′ end to provide for a random subset of amplicons.
12 . A kit comprising one or more primers as defined in claim 1 .
13 . A kit comprising one or more adaptors as defined in claim 1 .
14 . A kit comprising primers and adaptors as defined in claim 1 .
15 . A method for identifying the clonal source of a restriction fragment, comprising:
(a) digesting artificial chromosome clones in a plurality of pools with one or more restriction endonucleases to provide for a set of restriction fragments for each pool, and wherein each clone is present in more than one pool; (b) ligating adaptors to one or both sides of the restriction fragments, wherein at least one adaptor contains a pool-specific identifier or a degenerate identifier section, respectively, to provide adaptor-ligated restriction fragments; (c) sequencing at least the pool-specific identifier and part of the restriction fragment; and (d) assigning the restriction fragment sequences of step (c) to the corresponding clonal sources using the pool-specific identifiers.
16 . A kit comprising one or more adaptors as defined in claim 15 .Join the waitlist — get patent alerts
Track US2016251713A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.